XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.4
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
shares in Thousands, $ in Millions
Dec. 28, 2024
Sep. 28, 2024
Current assets:    
Cash and cash equivalents $ 30,299 $ 29,943
Marketable securities 23,476 35,228
Accounts receivable, net 29,639 33,410
Vendor non-trade receivables 29,667 32,833
Inventories 6,911 7,286
Other current assets 13,248 14,287
Total current assets 133,240 152,987
Non-current assets:    
Marketable securities 87,593 91,479
Property, plant and equipment, net 46,069 45,680
Other non-current assets 77,183 74,834
Total non-current assets 210,845 211,993
Total assets 344,085 364,980
Current liabilities:    
Accounts payable 61,910 68,960
Other current liabilities 61,151 78,304
Deferred revenue 8,461 8,249
Commercial paper 1,995 9,967
Term debt 10,848 10,912
Total current liabilities 144,365 176,392
Non-current liabilities:    
Term debt 83,956 85,750
Other non-current liabilities 49,006 45,888
Total non-current liabilities 132,962 131,638
Total liabilities 277,327 308,030
Commitments and contingencies
Common stock, shares outstanding (in shares) 15,040,731 15,116,786
Common stock, shares issued (in shares) 15,040,731 15,116,786
Shareholders’ equity:    
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 15,040,731 and 15,116,786 shares issued and outstanding, respectively $ 84,768 $ 83,276
Accumulated deficit (11,221) (19,154)
Accumulated other comprehensive loss (6,789) (7,172)
Total shareholders’ equity 66,758 56,950
Total liabilities and shareholders’ equity $ 344,085 $ 364,980